Institutional ownership · Form 13F

MED institutional ownership

MEDIFAST INC: reported institutional holdings as of 2026-06-30 (filed through 2026-08-31), aggregated by StockEyes from SEC Form 13F information tables. MED is one of 2732 tickers in the validated publication set. Mapping coverage in this publication set: 4562 of 6046 universe tickers have at least one validated CUSIP mapping (75.5%). Latest-quarter filed value resolved to any listed ticker: 77.3%; resolved to this universe: 77.2%.

Quarter ended2026-06-30 Filed through2026-08-31 Reporting managers114 Reported shares8,261,843 Value as filed$86,917,051
What changed this quarter

MED: change since the prior quarter's filings

More managers reported a position, with the count rising from 111 in the quarter ended 2026-03-31 to 114 in the quarter ended 2026-06-30 (+3, 2.7%). Total reported shares fell to 8,261,843 (-340,634, 4.0%), against the direction of the manager count. Among the 23 managers listed as top holders in both quarters, the largest increases were TWO SIGMA INVESTMENTS, LP (+143,223 shares) and AMERICAN CENTURY COMPANIES INC (+94,631 shares), among 12 managers who added shares, and the largest decreases were BlackRock, Inc. (-574,950 shares) and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (-234,543 shares), among 8 managers who reduced shares. MARSHALL WACE, LLP (241,649 shares), COMMONS CAPITAL, LLC (149,916 shares) and 5 more entered the listed top holders; Man Group plc (236,212 shares in the prior quarter), STATE STREET CORP (222,638 shares in the prior quarter) and 5 more dropped out of the listed top holders.

New to 13F data? Read how to read a 13F filing, or see where institutions moved overall in the Smart Money Report.

As filed

Reported totals, quarter ended 2026-06-30

114 reporting managers held 8,261,843 shares, reported value $86,917,051 exactly as filed. Values are position values transcribed from the filings, not current market prices.

Reported quarter-over-quarter change (quarter ended 2026-03-31 to quarter ended 2026-06-30): reporting managers +3, reported shares -340,634 (-3.96%), reported value -0.51%. These changes compare two filing snapshots.

Shares outstanding check: 11,135,000 shares reported by the issuer (SEC XBRL, period ended 2026-06-30). Reported 13F shares equal 74.2% of that figure. This page passed the publication sanity gate before listing.

What the data shows

MED in this quarter's filings

Concentration check: the largest reported position, RENAISSANCE TECHNOLOGIES LLC with 778,610 shares, is 9.4% of all shares reported for MED this quarter. The five largest reporting managers together account for 34.0% of the reported total, so the headline total is spread across a broad manager base rather than a few holders.

Reported quarter-over-quarter change: the reporting-manager count rose by 3 versus the quarter ended 2026-03-31, and reported shares moved -3.96% (-340,634 shares). That is a comparison of two filing snapshots, not a record of trades on any single day.

Shares-outstanding cross-check: reported 13F shares equal 74.2% of the issuer share count used at the publication gate (11,135,000 shares, issuer period ended 2026-06-30). The gate publishes a ticker only when that relationship is plausible; lending chains can push reported totals above a simple ownership share, which is why the figure is a sanity check and not an ownership percentage.

Top holders as filed

Largest reporting managers, MED

MED largest 13F reporting managers, quarter ended 2026-06-30
#ManagerSharesValue as filedShare of reported total
1RENAISSANCE TECHNOLOGIES LLC778,610$8,261,0529.4%
2Steamboat Capital Partners, LLC706,699$7,498,0768.6%
3TWO SIGMA INVESTMENTS, LP481,381$5,107,4525.8%
4VANGUARD CAPITAL MANAGEMENT LLC446,614$4,738,5755.4%
5CHARLES SCHWAB INVESTMENT MANAGEMENT INC396,996$4,212,1284.8%
6BlackRock, Inc.369,503$3,920,4274.5%
7DIMENSIONAL FUND ADVISORS LP363,394$3,855,6694.4%
8AMERICAN CENTURY COMPANIES INC318,911$3,383,6463.9%
9MORGAN STANLEY292,508$3,103,5243.5%
10GOLDMAN SACHS GROUP INC243,085$2,579,1322.9%
11MARSHALL WACE, LLP241,649$2,563,8972.9%
12AQR CAPITAL MANAGEMENT LLC236,434$2,508,5642.9%
13Peapod Lane Capital LLC222,576$2,361,5312.7%
14Lido Advisors, LLC220,337$2,337,7792.7%
15Trexquant Investment LP212,684$2,256,5772.6%

Manager names and figures are transcribed from each manager's own Form 13F information table. A manager listing shares in this snapshot does not mean it holds them today.

Quarter comparison

Reported change, 2026-03-31 to 2026-06-30

MED reported 13F totals by quarter
Quarter endedFiled throughReporting managersReported sharesValue as filed
2026-03-312026-05-291118,602,477$87,365,817
2026-06-302026-08-311148,261,843$86,917,051

Every change figure on this page is a reported quarter-over-quarter change between filing snapshots. It is not real-time trading activity.

Reported history

MED reported totals over time

Quarter ended 2026-06-30: 114 reporting managers · 8,261,843 reported shares · $86,917,051 value as filed.

The full archived series is part of StockEyes Pro. Continue with Google to sign in.

Quarter-end 13F filed data, long positions only; filings arrive up to 45 days after quarter end.

Coverage for this ticker

CUSIPs behind the MED total

The validated bridge mapped 1 current CUSIP(s) to MED for this quarter: 58470H101. Option pseudo-CUSIPs, units, warrants, and preferred classes are excluded from these common-share totals. Mapping coverage in this publication set: 4562 of 6046 universe tickers have at least one validated CUSIP mapping (75.5%). Latest-quarter filed value resolved to any listed ticker: 77.3%; resolved to this universe: 77.2%.

Read this first

What this page is and is not

Form 13F reports are quarterly holdings snapshots. Managers file up to about 45 days after quarter-end, so these figures describe reported positions as of the quarter-end date, not holdings today. 13F lists reportable long positions from managers above the SEC reporting threshold and omits short positions entirely.

This page is informational only. It is not investment advice, a recommendation, or a signal to buy or sell. Source: SEC Form 13F bulk data set for filings through 2026-08-31 (period ended 2026-06-30), joined to tickers through StockEyes' validated CUSIP bridge. Methodology and coverage are documented on the institutional ownership hub.

Insider transactions for MED (officer and director buys and sells) are covered by InsiderTrace: insidertrace.com/stock/med. StockEyes does not duplicate insider transaction tables.

Keep researching

Related StockEyes pages

Latest headlines tagged MED are on the market news wire. Upcoming earnings and market dates are on the events calendar. The term itself is defined in the institutional investor glossary entry, and the research workflow behind pages like this one is walked through in how to research a stock and how to compare SEC filings.

← All institutional ownership